Table 2.
Characteristics of patients in the URD vs Control analysis.
| Controls (n = 20) | RICT/URD (n = 96) | p-value | |
|---|---|---|---|
| Gender F/M – n (%) | 10 (50)/10 (50) | 36 (38)/60 (63) | NS |
| Median age at Inclusion, years (min–max) | 63 (55–69) | 64 (52–71) | NS |
| Risk group IR/HR – n (%) | 10 (50)/10 (50) | 46 (48)/50 (52) | NS |
| Median time from diagnosis to inclusion, days (min–max) | 57 (32–160) | 64 (28–244) | NS |
| Given therapy | |||
| Chemotherapy only | 14 | 16 | |
| Transplanted | 6a | 80b | |
| Median time from inclusion to transplant, days (min–max) | 93 (23–302) | ||
| Cause of death – n (%) | NS | ||
| GvHD or rel inf | – | 1 (1) | |
| Infection | 1 (5) | 5 (5) | |
| Other | 0 | 3 (3) | |
| Relapse | 10 (50) | 30 (31) | |
| Secondary malignancy | 1 (5) | 0 | |
a1 cord blood, 5 haploidentical HCT.
bAll RICT/URD.